Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

PARNAX LAB LTD. - 506128 - Closure of Trading Window

 Pursuant to BSE Circular dated 2nd April, 2019 vide Ref. No. LIST/COMP/01/2019-20, please note that the Trading Window for dealing in the Securities of the Company will remain closed for all the designated person w.e.f. 01st July, 2023, for the purpose of consideration of Unaudited Financial Results for the Quarter Ended and Three Months ended 30th June, 2023. The Trading Window shall open 48 hours after the Unaudited Financial Result for the Quarter and Three Months ended 30th June, 2023, becomes generally available to the public. The above is for your information and record.
30-06-2023
Bigul

Annual report for Parnax Lab Ltd. for FY-2023
31-05-2023
Bigul

PARNAX LAB LTD. - 506128 - Compliances-Reg.24(A)-Annual Secretarial Compliance

 Pursuant to Regulation 24A of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular no. CIR/CFD/CMD1/27/2019 dated February 08, 2019, please find enclosed Secretarial Compliance Report certified by HSPN & Associates LLP, Practicing Company Secretary of the Company for the financial year ended March 31, 2023. This is for your information and record.
30-05-2023
Bigul

PARNAX LAB LTD. - 506128 - Results-Audited Financial Results For The Quarter And Year Ended March 31, 2023

 Kindly find enclosed herewith the following: 1. A Copy of Standalone & Consolidated Audited Financial Results of the Company for the quarter and year ended 31st March, 2023, along with the Auditor's Report thereon, pursuant to regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) (Amendment) Regulations, 2015. 2. Declaration pursuant to Regulation 33(3)(d) as amended by the SEBI (Listing Obligations and Disclosure Requirements) (Amendment) Regulations, 2015. (A declaration is attached herewith as Annexure-I). We hereby declare that the Auditors have expressed an unmodified opinion in the Audit Report on the Standalone Audited Financial Results for the quarter and year ended March 31, 2023, and as required we submit Annexure-I in the prescribed format thereby furnishing the Statement of Audit Report with unmodified opinion)
30-05-2023
Bigul

PARNAX LAB LTD. - 506128 - Board Meeting Outcome for Outcome Of Board Meeting

 Pursuant to the provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) 2015, we wish to inform you that the Board of Directors of the Company at its meeting held today i.e., Tuesday, 30th May, 2023 at its Registered Office, the Board inter alia has transacted the following business: 1. Approval of Audited Standalone & Consolidated Financial Results for the quarter and year ended 31st March 2023, along with Auditor's Report thereon, pursuant to regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) (Amendment) Regulations, 2015. 2. Declaration pursuant to Regulation 33(3)(d) as amended by the SEBI (Listing Obligations and Disclosure Requirements) (Amendment) Regulations, 2015. The Meeting commenced at 5.00 p.m. and concluded at 6.30 p.m.
30-05-2023
Bigul

PARNAX LAB LTD. - 506128 - Board Meeting Intimation for Approval Of Audited Stand-Alone And Consolidated Financial Results For The Quarter And Year Ended March 31, 2023.

 PARNAX LAB LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2023 ,inter alia, to consider and approve 1. Standalone and Consolidated Audited IND- AS Compliant Financial Results along with Auditor Report for the quarter and year ended 31st March, 2023, pursuant to Regulation 33 of Listing Obligation and Disclosure Requirement, 2015. 2. Any other business with the permission of the chair and with the consent of a majority of the Directors present in the Meeting including at least one Independent Director. The approved results will be sent to you after the conclusion of the Board meeting.
22-05-2023
Bigul

PARNAX LAB LTD. - 506128 - Reply To Clarification On Price Movement

 With reference to your letter dated April 27, 2023, we wish to inform you that movement in price of securities is purely because of investors' perceptions based on information already disseminated to stock Exchange. We would also like to inform you that the Company has disclosed material information wherever applicable, from time to time for investor information. To the best of our knowledge and belief, currently there is no material information or announcement pending to disseminate that in our opinion would have bearing on the price behavior in the scrip.
28-04-2023
Bigul

PARNAX LAB LTD. - 506128 - Clarification sought from Parnax Lab Ltd

 The Exchange has sought clarification from Parnax Lab Ltd on April 27, 2023 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited.
28-04-2023
Bigul

PARNAX LAB LTD. - 506128 - Compliance As Per Regulation 49(9) Of Listing Obligation And Disclosure Requirement Regulation, 2015

 Please find enclosed herewith the Certificate as per Regulation 40(9) of the Listing Obligations and Disclosure Requirement Regulation, 2015, for the year ended 31st March, 2023. Kindly take the same on your record and acknowledge receipt of the same.
24-04-2023
Bigul

PARNAX LAB LTD. - 506128 - Compliance Certificate For The Year Ended March 31, 2023

 Enclosed please find the Certificate as per Regulation 7(3) of the Listing Obligations and Disclosure Requirement Regulation, 2015, for the year ended 31st March, 2023. Kindly take the same on your record and acknowledge receipt of the same.
13-04-2023
Next Page
Close

Let's Open Free Demat Account